ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)

Clinical trial NCT00856024 · TERMINATED

Trial details

NCT number: NCT00856024
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Study type: OBSERVATIONAL

Hepatitis C, Chronic

Start date: 2008-07-01
Primary completion: 2010-10-01
Enrollment: 902

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.